Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases [Phase 4]
Phase 4 clinical trial evaluating alpha-lipoic acid for non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Comparison of Effectiveness of Obeticholic Acid With Vitamin E in Patients of Non-alcoholic Fatty Liver Disease [Phase 2]
Phase 2 trial comparing Obeticholic Acid with Vitamin E in non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) [Phase 3]
Clinical trial update for a Phase 3 open-label extension (MAESTRO-NAFLD-OLE) of resmetirom (MGL-3196) in non-alcoholic fatty liver disease, …
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Assessment of Tolerability of Specialized Food Products Made Out of Vegetable Protein and Their Influence on Lipid Profile in Patients With Non-alcoholic Fatty Liver Disease [NA]
A clinical trial update describes a planned study to assess tolerability of vegetable-protein-based specialized foods and their effect on li…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Effect of Adjustable Intragastric Balloon in Obese Non-alcoholic Fatty Liver Disease [NA]
A completed clinical trial assessing the effect of an adjustable intragastric balloon in obese individuals with non-alcoholic fatty liver di…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Probiotic Supplement Versus Placebo for the Treatment of Patients With Non-alcoholic Fatty Liver Disease [NA]
A completed clinical trial evaluated a probiotic supplement versus placebo for non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease
A clinical trial update reports recruiting participants to evaluate a non-invasive screening tool for predicting metabolic dysfunction-assoc…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)
A clinical trial investigating macrophage lysosomal lipid metabolism in obesity is currently recruiting, with obesity, non-alcoholic fatty l…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease [Phase 1]
Phase 1 trial evaluating AZD7503 for HSD17B13 mRNA knockdown with pharmacokinetics, safety, and tolerability data in non-alcoholic fatty liv…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load [Phase 4]
A Phase 4 trial assessed the efficacy and safety of a rilpivirine-based antiretroviral regimen in HIV-infected patients with non-alcoholic f…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Characteristics of NAFLD Among Type 2 Diabetes Patients [NA]
This clinical trial update describes characteristics of non-alcoholic fatty liver disease among patients with type 2 diabetes, and the study…
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: Lifestyle Guidance Methods in NAFLD [NA]
A completed clinical trial evaluating lifestyle guidance methods for non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: Prevalence of NAFLD in ACS Patients [NA]
This clinical trial update reports the prevalence of non-alcoholic fatty liver disease in patients with acute coronary syndrome and notes th…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant [Phase 2]
Phase 2 randomized, double-blind, placebo-controlled trial of semaglutide to prevent weight gain after liver transplantation in patients wit…
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) [Phase 4]
Phase 4 trial update on metformin for ectopic fat deposition and metabolic markers in polycystic ovary syndrome; the study was terminated an…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Implementation of the Fatty Liver Index in Primary Care [NA]
Completed clinical trial evaluating the implementation of the Fatty Liver Index in primary care to screen for hepatic steatosis among patien…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Low-Calorie Diet in People With Prediabetes/Metabolic Syndrome [NA]
A completed clinical trial evaluating a low-calorie diet in people with prediabetes and metabolic syndrome, with obesity and non-alcoholic f…
-
EMA approval · 2025-06-20First treatment against liver scarring caused by a type of ‘fatty liver disease’
EMA approved the first treatment for liver scarring caused by a fatty liver disease. The drug is indicated for adults with moderate to advan…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Liver Health and Metabolic Function in People With Obesity [NA]
A completed clinical trial evaluating liver health and metabolic function in people with obesity. The study focuses on Non-Alcoholic Fatty L…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using Fibroscan
A completed clinical trial evaluating liver stiffness and hepatic steatosis in women with polycystic ovary syndrome using FibroScan.
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease [EARLY_Phase 1]
Clinical trial update for NeuroFLiPP, an early Phase 1 study using parametric PET to image neuroinflammation in non-alcoholic fatty liver di…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Influence of the Diversity and Composition of the Microbiota in the Development of Pediatric Fatty Liver [NA]
A completed clinical trial investigating how the gut microbiota's diversity and composition may influence the development of pediatric non-a…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease
A clinical trial at Queen Mary University of London is investigating pathological mechanisms in non-alcoholic fatty liver disease and is cur…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial is evaluating pioglitazone plus empagliflozin for fatty liver disease in people with type 2 diabetes and is current…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Reversal of Lipid-Induced Insulin Resistance [NA]
A clinical trial update indicating that a study on reversing lipid-induced insulin resistance is currently recruiting. The conditions includ…